Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/10/2002US20020146762 Generating mutant polypeptides; obtain protein sample, incubate wih mutagen, recover and evaluate protein activity
10/10/2002US20020146761 Detecting gram-negative bacterial infection in human; btain human, inject with labeled endotoxin neutralizing protein, detect label
10/10/2002US20020146760 G protein-coupled receptor for use in treatment of alzheimer's disease
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146758 Polypeptide for use in the treatment of infections, stroke, reperfusion injuries, nervous system, blood, vision, brain and bone disorders
10/10/2002US20020146757 Nucleotide sequences coding polypeptide for use in the treatment of, muscle, blood, nervous system, gastrointestinal and vision defects
10/10/2002US20020146750 Mucin for use in the diagnosiss and treatment of cancer
10/10/2002US20020146748 Immunological detection of neosporosis using a recombinant antigen
10/10/2002US20020146747 TRAC1: modulators of lymphocyte activation
10/10/2002US20020146740 Monitoring ligand binding to membrane proteins; obtain sample containing membrane proteins, incubate with ligands, detect binding of ligands
10/10/2002US20020146739 Method for the affinity isolation of newly synthesized RNA
10/10/2002US20020146728 IGF-1 receptor interacting proteins
10/10/2002US20020146727 Compositions and methods for the therapy and diagnosis of breast cancer
10/10/2002US20020146719 Diagnosing narcolepsy in humans; obtain nucleotide sequences, detect mutation, presence of mutation indicates narcolepsy
10/10/2002US20020146718 Peptide nucleic acids for use in the treatment and prevention of viral diseases, arthritis, infection, skin, cardiovascular, gastrointestinal and kidney disorders
10/10/2002US20020146713 DNA test for SCA-10
10/10/2002US20020146712 Tumor suppressor
10/10/2002US20020146711 MMSC2 - an MMAC1 interacting protein
10/10/2002US20020146710 Detecting preferental polypeptide in sample; obtain cells, transform with vector, recover transformed cells, monitor and evaluate gene expression in transformed cells
10/10/2002US20020146709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/10/2002US20020146708 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer
10/10/2002US20020146707 Cardiotrophin-1 compositions and methods for the treatment of tumor
10/10/2002US20020146702 Nucleic acid molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
10/10/2002US20020146701 Protein complex for monitoring protein associations in sample
10/10/2002US20020146693 Isolation and identification of secreted proteins
10/10/2002US20020146692 Methods and materials relating to G protein-coupled receptor-like polypeptides and polynucleotides
10/10/2002US20020146687 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding
10/10/2002US20020146685 Kit for use in the accurate detection of viral infections
10/10/2002US20020146684 Generating preferential compounds; obtain protection compounds, incubate with chemical intermediates, remove terminal buliding blocks, recover compound
10/10/2002US20020146683 Modified hiv env polypeptides
10/10/2002US20020146504 Ternary biomolecule/polymer/surface-based immobilization systems
10/10/2002US20020146434 As vaccine or gene vaccine; diagnostic reagent capable of accurately detecting infections with an epidemic strain of measles virus
10/10/2002US20020146432 Porcine circoviruses, vaccines and diagnostic reagents
10/10/2002US20020146431 For prophylaxis of porcine multisystemic wasting syndrome (PMWS)
10/10/2002US20020146427 DNA encoding bovine immunoglobulin a inducing protein and uses therefor
10/10/2002US20020146426 Administering molecule joined to a heat shock protein or molecule joined to an adenosinetriphosphate (ATP) binding domain of a heat shock protein inducing an immune response that includes a CD8+ cytotoxic T lymphocyte (CTL) response
10/10/2002US20020146423 Protective helicobacter antigens
10/10/2002US20020146421 Diagnosis and treatment of malignant neoplasms
10/10/2002US20020146420 Protein tyrosine kinase agonist antibodies
10/10/2002US20020146419 Methods of treating ankylosis with chimeric anti-TNF antibodies
10/10/2002US20020146418 For use in therapy
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002US20020146409 Providing a blood protein solution; adding hydroxypropyl-alpha -cyclodextrin in to form a stable complex with the protein; lyophilizing the solution of step to form a lyophilized protein/hydroxypropyl- alpha -cyclodextrin complex
10/10/2002US20020146408 Human haemopoietic maturation factor
10/10/2002US20020146406 Polypeptides with therapeutic activity and methods of use
10/10/2002US20020146395 Methods of inducing nervous tissue regeneration
10/10/2002US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002US20020146389 For inducing apoptosis in mammalian cancer cells; stimulating a proinflammatory response in mammalian cells
10/10/2002US20020146388 Cytokine immunoconjugates
10/10/2002DE10117430A1 Hochempfindlicher und hochspezifischer Enzymnachweis mit einer Nachweisgrenze bis in den femtomolaren Bereich Highly sensitive and highly specific enzyme detection with a detection limit up to femtomolar concentrations
10/10/2002DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
10/10/2002DE10115073A1 Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren Use of inhibitors of IKK-ß and methods for finding such inhibitors
10/10/2002DE10114063A1 New DNA sequences from potato, useful for producing plants with altered properties, e.g. tolerance of flooding, also related proteins, antibodies and inhibitory sequences
10/10/2002CA2455915A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002CA2447183A1 Molecules for disease detection and treatment
10/10/2002CA2446804A1 Secreted streptococcus pneumoniae proteins
10/10/2002CA2445499A1 Fizz1 for metabolism regulation
10/10/2002CA2443338A1 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
10/10/2002CA2443324A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002CA2443179A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002CA2443176A1 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
10/10/2002CA2443138A1 Anti-muc-1 single chain antibodies for tumor targeting
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2443045A1 Mucin peptide with immunoenhancing properties
10/10/2002CA2442944A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442847A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2442843A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002CA2442841A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/10/2002CA2442835A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002CA2442808A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442774A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442755A1 Methods for modification of plant inflorescence architecture
10/10/2002CA2442718A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442684A1 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002CA2442619A1 Cancer-testis antigens
10/10/2002CA2442607A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof
10/10/2002CA2442594A1 Vip3 pesticidal toxin from bacillus thuringiensis
10/10/2002CA2442587A1 Method for improving plant tolerance to environmental stress
10/10/2002CA2442531A1 Peptides and antibodies to muc 1 proteins
10/10/2002CA2442526A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442496A1 Method for modifying plant biomass
10/10/2002CA2442495A1 Alpha conotoxin peptides with analgesic properties
10/10/2002CA2442363A1 Reducing the immunogenicity of fusion proteins
10/10/2002CA2442346A1 Nucleic acids encoding isav polypeptides
10/10/2002CA2442298A1 Leishmania vaccines
10/10/2002CA2442177A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002CA2442134A1 Compositions and methods for diagnosing or treating psoriasis
10/10/2002CA2442123A1 Adp-ribosylating bacterial toxins
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2442020A1 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002CA2441654A1 Cytoskeleton-associated proteins
10/10/2002CA2441562A1 Short bioactive peptides and methods for their use
10/10/2002CA2441382A1 A hepatitis b virus surface antigen mutant and methods of detection thereof
10/10/2002CA2441327A1 Human arginine-rich protein-related compositions
10/10/2002CA2441084A1 Improved conditionally replicating vectors for inhibiting viral infections
10/10/2002CA2440874A1 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2438030A1 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
1 ... 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 ... 2916